1. Home
  2. VSTS vs HRMY Comparison

VSTS vs HRMY Comparison

Compare VSTS & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vestis Corporation

VSTS

Vestis Corporation

HOLD

Current Price

$7.59

Market Cap

572.2M

Sector

N/A

ML Signal

HOLD

Logo Harmony Biosciences Holdings Inc.

HRMY

Harmony Biosciences Holdings Inc.

HOLD

Current Price

$40.40

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VSTS
HRMY
Founded
1936
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
572.2M
2.0B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
VSTS
HRMY
Price
$7.59
$40.40
Analyst Decision
Sell
Strong Buy
Analyst Count
4
9
Target Price
$5.95
$51.33
AVG Volume (30 Days)
3.2M
789.9K
Earning Date
01-30-2026
11-04-2025
Dividend Yield
0.46%
N/A
EPS Growth
N/A
50.44
EPS
N/A
3.17
Revenue
$2,734,839,000.00
$825,944,000.00
Revenue This Year
$1.47
$23.11
Revenue Next Year
$3.06
$16.15
P/E Ratio
N/A
$12.79
Revenue Growth
N/A
21.13
52 Week Low
$3.98
$25.52
52 Week High
$16.68
$40.93

Technical Indicators

Market Signals
Indicator
VSTS
HRMY
Relative Strength Index (RSI) 75.53 80.09
Support Level $7.10 $38.12
Resistance Level $7.71 $40.00
Average True Range (ATR) 0.40 1.20
MACD 0.09 0.25
Stochastic Oscillator 95.44 100.00

Price Performance

Historical Comparison
VSTS
HRMY

About VSTS Vestis Corporation

Vestis Corp is a provider of uniform rentals and workplace supplies across the United States and Canada. It provides uniforms, mats, towels, linens, restroom supplies, first-aid supplies, safety products, and other workplace supplies. The Company serves customers ranging from small, family-owned operations with a single location to large corporations and national franchises with multiple locations. The company operates in the United States and Canada as reportable segments. The company earns the majority of its revenue from the United States.

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

Share on Social Networks: